Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.
<h4>Background</h4>Aortic stenosis is the most common age-related valvular pathology. Patients with aortic stenosis and myocardial fibrosis have worse outcome but the underlying mechanism is unclear. Lipoprotein(a) is associated with adverse cardiovascular risk and is elevated in patient...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181077&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695148026363904 |
|---|---|
| author | Vassilios S Vassiliou Paul D Flynn Claire E Raphael Simon Newsome Tina Khan Aamir Ali Brian Halliday Annina Studer Bruengger Tamir Malley Pranev Sharma Subothini Selvendran Nikhil Aggarwal Anita Sri Helen Berry Jackie Donovan Willis Lam Dominique Auger Stuart A Cook Dudley J Pennell Sanjay K Prasad |
| author_facet | Vassilios S Vassiliou Paul D Flynn Claire E Raphael Simon Newsome Tina Khan Aamir Ali Brian Halliday Annina Studer Bruengger Tamir Malley Pranev Sharma Subothini Selvendran Nikhil Aggarwal Anita Sri Helen Berry Jackie Donovan Willis Lam Dominique Auger Stuart A Cook Dudley J Pennell Sanjay K Prasad |
| author_sort | Vassilios S Vassiliou |
| collection | DOAJ |
| description | <h4>Background</h4>Aortic stenosis is the most common age-related valvular pathology. Patients with aortic stenosis and myocardial fibrosis have worse outcome but the underlying mechanism is unclear. Lipoprotein(a) is associated with adverse cardiovascular risk and is elevated in patients with aortic stenosis. Although mechanistic pathways could link Lipoprotein(a) with myocardial fibrosis, whether the two are related has not been previously explored. In this study, we investigated whether elevated Lipoprotein(a) was associated with the presence of myocardial replacement fibrosis.<h4>Methods</h4>A total of 110 patients with mild, moderate and severe aortic stenosis were assessed by late gadolinium enhancement (LGE) cardiovascular magnetic resonance to identify fibrosis. Mann Whitney U tests were used to assess for evidence of an association between Lp(a) and the presence or absence of myocardial fibrosis and aortic stenosis severity and compared to controls. Univariable and multivariable linear regression analysis were undertaken to identify possible predictors of Lp(a).<h4>Results</h4>Thirty-six patients (32.7%) had no LGE enhancement, 38 (34.6%) had midwall enhancement suggestive of midwall fibrosis and 36 (32.7%) patients had subendocardial myocardial fibrosis, typical of infarction. The aortic stenosis patients had higher Lp(a) values than controls, however, there was no significant difference between the Lp(a) level in mild, moderate or severe aortic stenosis. No association was observed between midwall or infarction pattern fibrosis and Lipoprotein(a), in the mild/moderate stenosis (p = 0.91) or severe stenosis patients (p = 0.42).<h4>Conclusion</h4>There is no evidence to suggest that higher Lipoprotein(a) leads to increased myocardial midwall or infarction pattern fibrosis in patients with aortic stenosis. |
| format | Article |
| id | doaj-art-abbb406520b44f0aa5596c697f958ca4 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-abbb406520b44f0aa5596c697f958ca42025-08-20T03:19:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018107710.1371/journal.pone.0181077Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.Vassilios S VassiliouPaul D FlynnClaire E RaphaelSimon NewsomeTina KhanAamir AliBrian HallidayAnnina Studer BruenggerTamir MalleyPranev SharmaSubothini SelvendranNikhil AggarwalAnita SriHelen BerryJackie DonovanWillis LamDominique AugerStuart A CookDudley J PennellSanjay K Prasad<h4>Background</h4>Aortic stenosis is the most common age-related valvular pathology. Patients with aortic stenosis and myocardial fibrosis have worse outcome but the underlying mechanism is unclear. Lipoprotein(a) is associated with adverse cardiovascular risk and is elevated in patients with aortic stenosis. Although mechanistic pathways could link Lipoprotein(a) with myocardial fibrosis, whether the two are related has not been previously explored. In this study, we investigated whether elevated Lipoprotein(a) was associated with the presence of myocardial replacement fibrosis.<h4>Methods</h4>A total of 110 patients with mild, moderate and severe aortic stenosis were assessed by late gadolinium enhancement (LGE) cardiovascular magnetic resonance to identify fibrosis. Mann Whitney U tests were used to assess for evidence of an association between Lp(a) and the presence or absence of myocardial fibrosis and aortic stenosis severity and compared to controls. Univariable and multivariable linear regression analysis were undertaken to identify possible predictors of Lp(a).<h4>Results</h4>Thirty-six patients (32.7%) had no LGE enhancement, 38 (34.6%) had midwall enhancement suggestive of midwall fibrosis and 36 (32.7%) patients had subendocardial myocardial fibrosis, typical of infarction. The aortic stenosis patients had higher Lp(a) values than controls, however, there was no significant difference between the Lp(a) level in mild, moderate or severe aortic stenosis. No association was observed between midwall or infarction pattern fibrosis and Lipoprotein(a), in the mild/moderate stenosis (p = 0.91) or severe stenosis patients (p = 0.42).<h4>Conclusion</h4>There is no evidence to suggest that higher Lipoprotein(a) leads to increased myocardial midwall or infarction pattern fibrosis in patients with aortic stenosis.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181077&type=printable |
| spellingShingle | Vassilios S Vassiliou Paul D Flynn Claire E Raphael Simon Newsome Tina Khan Aamir Ali Brian Halliday Annina Studer Bruengger Tamir Malley Pranev Sharma Subothini Selvendran Nikhil Aggarwal Anita Sri Helen Berry Jackie Donovan Willis Lam Dominique Auger Stuart A Cook Dudley J Pennell Sanjay K Prasad Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. PLoS ONE |
| title | Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. |
| title_full | Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. |
| title_fullStr | Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. |
| title_full_unstemmed | Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. |
| title_short | Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. |
| title_sort | lipoprotein a in patients with aortic stenosis insights from cardiovascular magnetic resonance |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181077&type=printable |
| work_keys_str_mv | AT vassiliossvassiliou lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT pauldflynn lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT claireeraphael lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT simonnewsome lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT tinakhan lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT aamirali lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT brianhalliday lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT anninastuderbruengger lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT tamirmalley lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT pranevsharma lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT subothiniselvendran lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT nikhilaggarwal lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT anitasri lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT helenberry lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT jackiedonovan lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT willislam lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT dominiqueauger lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT stuartacook lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT dudleyjpennell lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance AT sanjaykprasad lipoproteinainpatientswithaorticstenosisinsightsfromcardiovascularmagneticresonance |